← Alle Unternehmen
Über das Unternehmen
At ReproNovo, we are redefining what's possible in reproductive medicine and women’s health. We are advancing innovative therapeutic solutions for both male and female infertility, as well as pioneering treatment options for uterine conditions like adenomyosis, delivering meaningful change to patients worldwide. Our international team brings together deep expertise across reproductive medicine, drug development, regulatory strategy, and business development—with a proven track record of bringing multiple therapies to market. ReproNovo is backed by leading investors including Jeito Capital, AXA IM Alts, M Ventures, Ysios Capital, and ALSA Ventures. Headquartered in Lausanne, Switzerland, our primary development team is located in Copenhagen, Denmark, with an additional development site in Barcelona, Spain. Imprint ReproNovo S.A. Rue de Langallerie 11 1003 Lausanne, Switzerland E-Mail: [email protected] Chief Executive Officer & Co-Founder: Jean Duvall Chief Scientific & Medical Officer & Co-Founder: Joan-Carles Arce Chief Financial Officer & Co-Founder: BingMei Hao